Carolyn received her Bachelor of Science from Monash University Science Faculty, majoring in Biochemistry and Immunology. She received her first class Honours and PhD in Immunology from the Monash University Medical Faculty. She undertook 2 post-doctoral placements, at the Necker Institute, Paris and the Sloan-Kettering Cancer Institute, New York focusing on cancer models, cellular death, autoimmunity and T cell development.
On returning to Australia Carolyn studied Intellectual Property Law at Melbourne University and thereafter took a senior scientific role in a Global Life Sciences Consultancy advising innovative Biotech and small Pharma on immunogenicity, risk management and pre-clinical development. After 5 years, Carolyn joined the Regulatory Affairs Department at GlaxoSmithKline Pharmaceuticals to assist in registering a significant pipeline of medicines, including oncology, vaccine, autoimmune and HIV advances with the Therapeutic Goods Administration (TGA). She became Director, Regulatory Affairs AU & NZ in 2013 and currently also resides on the Australian Executive team and the Greater China and Intercontinental Regulatory Affairs leadership team.
Carolyn is a company champion of diversity and equality and enjoys coaching and mentoring those, through her company, or as an invited speaker, who are at different stages of their scientific career journey.
You can find Carolyn on: